lobbying_activities: 508829

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
508829	50319651-ed2c-4f80-8e38-d84f2651aca8	MM	NATIONAL VENTURE CAPITAL ASSOCIATION	21687	NATIONAL VENTURE CAPITAL ASSOCIATION	2007	mid_year	MED	* FDA Reform User Fee Reauthorization S.1082 and HR 2900 to reauthorize the FDA user fees for prescription drugs nad medical devices; to reform the FDA regulatory process. Biogenerics Pathway HR 1038 and S 623 - Access to Life Savings Medicine Act HR 1956, Patient Protection and Innovative Biologics Medicine Act; S. 1695 Biologics Price Competition Act S.1859 and HR 3161 FY08 FDA Appropriations	Energy, Dept of,HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),White House Office		600000	0	0	2007-08-01T14:52:18-04:00